These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 4602055

  • 21. Treatment of essential hyperlipidaemia.
    Fredrickson DS, Levy RI.
    Lancet; 1970 Jan 24; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Probucol, blood lipids and the ECG QTc interval.
    Graham I, Ronan G, Comerford D, Hickey N, Daly L, Mulcahy R.
    Ir Med J; 1986 Feb 24; 79(2):45-7. PubMed ID: 3733408
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of probucol on hyperlipidemic patients with cardiac allografts.
    Anderson JL, Schroeder JS.
    J Cardiovasc Pharmacol; 1979 Feb 24; 1(3):353-65. PubMed ID: 94402
    [Abstract] [Full Text] [Related]

  • 28. Lipid lowering therapy in the treatment of lower limb atherosclerosis.
    Leng GC, Price JF, Jepson RG.
    Eur J Vasc Endovasc Surg; 1998 Jul 24; 16(1):5-6. PubMed ID: 9715709
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA, Toivonen I.
    Postgrad Med J; 1975 Jul 24; 51(8):suppl 71-5. PubMed ID: 215985
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of halofenate on serum lipids.
    Aronow WS, Harding PR, Khursheed M, Vangrow JS, Papageorge's NP, Mays J.
    Clin Pharmacol Ther; 1973 Jul 24; 14(3):358-65. PubMed ID: 4572798
    [No Abstract] [Full Text] [Related]

  • 35. Serum lipid disorders: what levels should you aim for?
    Rees ED.
    Geriatrics; 1981 Feb 24; 36(2):77-86. PubMed ID: 7450512
    [No Abstract] [Full Text] [Related]

  • 36. Comparative study of bezafibrate and probucol in hyperlipidaemia.
    Páez Moreno JP, González G.
    Curr Med Res Opin; 1989 Feb 24; 11(8):523-32. PubMed ID: 2680288
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Probucol reduces lysophosphatidylcholines in low-density lipoprotein.
    Yoshinari M, Shi AH, Yoshizumi H, Wakisaka M, Iwase M, Fujishima M.
    Eur J Clin Pharmacol; 2000 Feb 24; 55(11-12):787-92. PubMed ID: 10805055
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.